Bone Marrow Mesenchymal Stem Cell Transplantation in a Rabbit Corneal Alkali Bum Model (A Histological and Immune Histo-chemical Study)

被引:18
作者
Ahmed, Soheir Kamal [1 ]
Soliman, Amel Ali [1 ]
Omar, Sahar M. M. [1 ]
Mohammed, Wafaa Rabee [1 ]
机构
[1] Ain Shams Univ, Fac Med, Dept Histol, Cairo, Egypt
关键词
INTERMEDIATE-FILAMENTS; DESCEMETS-MEMBRANE; EPITHELIAL-CELLS; EXPRESSION; RECONSTRUCTION; DIFFERENTIATION; ENDOTHELIUM; VIMENTIN; SURFACE; INJURY;
D O I
10.15283/ijsc.2015.8.1.69
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Background: Alkali-burned corneas can seldom heal properly to restore corneal transparency. Treatment of this severe disorder of the ocular surface remains a challenge. Aim of the Work: was to investigate whether systemically transplanted bone marrow mesenchymal stem cells (BM-MSCs) can promote corneal wound healing after alkali burn. Material and Methods: Thirty five male New Zealand rabbits were used in this study. The animals were divided into three groups. Group I; the control group was sham operated. Group II; corneal alkali burn was created. Group III; underwent corneal alkali burn then treated with BM-MSCs. All corneas were collected after fourteen and twenty eight days. Evaluation using H&E, PAS & alkaline phosphatase reaction was carried out. Immune histo-chemical staining for CD44 and vimentin was performed as well. Results: the corneal epithelium of (Group II) showed marked alterations. Vascularization, cellular infiltration and irregularity of the collagen fibers were also seen in the substantia propria. Increase in the thickness of the Descemet's membrane was noticed as well. On the other hand, at the time of 28 days, Group III rabbits showed best histological results with nearly healed corneas compared to other groups. Meanwhile, vimentin was more strongly expressed in Group III assessing the differentiating ability of BM-MSCs. Conclusion: BM-MSCs could effectively promote corneal alkali burn healing.
引用
收藏
页码:69 / 78
页数:10
相关论文
共 31 条
[1]   Mesenchymal stem cells: Isolation and therapeutics [J].
Alhadlaq, A ;
Mao, JJ .
STEM CELLS AND DEVELOPMENT, 2004, 13 (04) :436-448
[2]   THE HYALURONATE RECEPTOR IS PREFERENTIALLY EXPRESSED ON PROLIFERATING EPITHELIAL-CELLS [J].
ALHO, AM ;
UNDERHILL, CB .
JOURNAL OF CELL BIOLOGY, 1989, 108 (04) :1557-1565
[3]   Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow [J].
Campagnoli, C ;
Roberts, IAG ;
Kumar, S ;
Bennett, PR ;
Bellantuono, I ;
Fisk, NM .
BLOOD, 2001, 98 (08) :2396-2402
[4]   Dynamics of the expression of intermediate filaments vimentin and desmin during myofibroblast differentiation after corneal injury [J].
Chaurasia, Shyam S. ;
Kaur, Harmeet ;
de Medeiros, Fabricio W. ;
Smith, Scott D. ;
Wilson, Steven E. .
EXPERIMENTAL EYE RESEARCH, 2009, 89 (02) :133-139
[5]   Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats [J].
Chen, JL ;
Li, Y ;
Wang, L ;
Zhang, ZG ;
Lu, DY ;
Lu, M ;
Chopp, M .
STROKE, 2001, 32 (04) :1005-1011
[6]  
Christmas B, 2011, J TRAUMA, V71, P289
[7]   Transplantation of human umbilical mesenchymal stem cells cures the corneal defects of mucopolysaccharidosis VII mice [J].
Coulson-Thomas, Vivien Jane ;
Caterson, Bruce ;
Kao, Winston W-Y. .
STEM CELLS, 2013, 31 (10) :2116-2126
[8]   Impact of Enhanced Mobilization of Bone Marrow Derived Cells to Site of Injury [J].
Hannoush, Edward J. ;
Sifri, Ziad C. ;
Elhassan, Ihab O. ;
Mohr, Alicia M. ;
Alzate, Walter D. ;
Offin, Michael ;
Livingston, David H. .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2011, 71 (02) :283-289
[9]   Myofibroblast Metaplasia After Descemet Membrane Endothelial Keratoplasty [J].
Heindl, Ludwig M. ;
Schloetzer-Schrehardt, Ursula ;
Cursiefen, Claus ;
Bachmann, Bjoern O. ;
Hofmann-Rummelt, Carmen ;
Kruse, Friedrich E. .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2011, 151 (06) :1019-1023
[10]   Mesenchymal Stem Cells, Nanofiber Scaffolds and Ocular Surface Reconstruction [J].
Holan, Vladimir ;
Javorkova, Eliska .
STEM CELL REVIEWS AND REPORTS, 2013, 9 (05) :609-619